IP Library Assignment 071490/0880
Patent Assignment
Reel/Frame 071490/0880

Partial Release of First Lien Intellectual Property Security Agreement Supplement

Recorded: 2025-06-03 Pages: 7
Assignor
APOLLO ADMINISTRATIVE AGENCY LLC
Executed: 2025-06-03
Assignee
CURIA GLOBAL, INC.
26 CORPORATE CIRCLE, ALBANY, NEW YORK, 12203
Covered Properties (10)
Aryl- and Heteroaryl-Substituted Tetrahydroisoquinolines and Use Thereof to Block Reuptake of Norepinephrine, Dopamine, and Serotonin
Patent: 7,541,357 →
Application: 11/183,066 →
Publication: US 2006/0052378
Aryl- and Heteroaryl-Substituted Tetrahydroisoquinolines and Use Thereof to Block Reuptake of Norepinephrine, Dopamine, and Serotonin
Patent: 8,227,486 →
Application: 12/252,823 →
Publication: US 2009/0048443
Aryl- and Heteroaryl-Substituted Tetrahydroisoquinolines and Use Thereof to Block Reuptake of Norepinephrine, Dopamine, and Serotonin
Patent: 8,236,796 →
Application: 12/417,598 →
Publication: US 2009/0253906
Crystalline Form of 6-[(4S)-2-Methyl-4-(2-Naphthyl)-1,2,3,4-Tetrahydroisoquinolin-7-Yl]Pyridazin-3-Amine
Patent: 8,445,494 →
Application: 12/995,771 →
Publication: US 2011/0160220
Tetrahydroisoquinolines and Intermediates Therefor
Patent: 8,420,811 →
Application: 12/995,776 →
Publication: US 2011/0077400
Aryl- and Heteroaryl-Substituted Tetrahydroisoquinolines and Use Thereof to Block Reuptake of Norepinephrine, Dopamine, and Serotonin
Patent: 8,741,901 →
Application: 13/540,446 →
Publication: US 2013/0005965
Crystalline Form of 6-[(4S)-2-Methyl-4-(2-Naphthyl)-1,2,3,4-Tetrahydroisoquinolin-7-Yl]Pyridazin-3-Amine
Patent: 9,156,812 →
Application: 13/845,919 →
Publication: US 2014/0275101
Aryl- and Heteroaryl-Substituted Tetrahydroisoquinolines and Use Thereof to Block Reuptake of Norepinephrine, Dopamine, and Serotonin
Patent: 9,085,531 →
Application: 14/268,753 →
Publication: US 2014/0243524
Aryl- and Heteroaryl-Substituted Tetrahydroisoquinolines and Use Thereof to Block Reuptake of Norepinephrine, Dopamine, and Serotonin
Patent: 9,499,531 →
Application: 14/737,897 →
Publication: US 2015/0274713
Crystalline Form of 6-[(4S)-2-Methyl-4-(2-Naphthyl)-1,2,3,4-Tetrahydroisoquinolin-7-Yl]Pyridazin-3-Amine
Patent: 9,498,476 →
Application: 14/841,024 →
Publication: US 2015/0366864
Related Assignments (12)
Other recorded transfers of the patents in this record — the chain of ownership.
Release of Security Interest Jul 9, 2014
From: WELLS FARGO
To: ALBANY MOLECULAR RESEARCH, INC.
Reel/Frame 033283/0357 →
Security Interest Oct 24, 2014
From: ALBANY MOLECULAR RESEARCH, INC.; ALO ACQUISITION LLC; AMRI BURLINGTON, INC.; AMRI RENSSELAER, INC.
To: BARCLAYS BANK PLC, AS THE COLLATERAL AGENT
Reel/Frame 034045/0951 →
Security Interest Aug 5, 2015
From: ALBANY MOLECULAR RESEARCH, INC.; AMRI SSCI, LLC
To: BARCLAYS BANK PLC, AS THE COLLATERAL AGENT
Reel/Frame 036257/0914 →
Assignment of Assignor's Interest Jun 22, 2016
From: BRISTOL-MYERS SQUIBB COMPANY
To: ALBANY MOLECULAR RESEARCH, INC.
Reel/Frame 039116/0827 →
Release of Security Interest Aug 31, 2017
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: ALBANY MOLECULAR RESEARCH, INC.; ALO ACQUISITION LLC; AMRI BURLINGTON, INC.; AMRI RENSSELAER, INC.
Reel/Frame 043742/0085 →
First Lien Security Agreement Sep 1, 2017
From: ALBANY MOLECULAR RESEARCH, INC.; AMRI BURLINGTON, INC.; CEDARBURG PHARMACEUTICALS, INC.; EUTICALS INC.
To: BARCLAYS BANK, PLC AS COLLATERAL AGENT
Reel/Frame 043746/0621 →
Second Lien Security Agreement Sep 1, 2017
From: ALBANY MOLECULAR RESEARCH, INC.; AMRI BURLINGTON, INC.; CEDARBURG PHARMACEUTICALS, INC.; EUTICALS INC.
To: MORGAN STANLEY SENIOR FUNDING, INC.
Reel/Frame 043746/0657 →
Corrective Assignment to Correct the Incorrect Patent No. 7541537 Previously Recorded at Reel: 034045 Frame: 0951. Assignor(S) Hereby Confirms the Security Interest. Aug 14, 2018
From: ALBANY MOLECULAR RESEARCH, INC.; ALO ACQUISITION LLC; AMRI BURLINGTON, INC.; AMRI RENSSELAER, INC.
To: BARCLAYS BANK PLC, AS THE COLLATERAL AGENT
Reel/Frame 046796/0352 →
Release of Security Interest Oct 29, 2020
From: MORGAN STANLEY SENIOR FUNDING, INC., AS COLLATERAL AGENT
To: ALBANY MOLECULAR RESEARCH, INC.; AMRI BURLINGTON, INC.; CEDARBURG PHARMACEUTICALS, INC.; EUTICALS INC.
Reel/Frame 054252/0687 →
Release of Security Interest Nov 16, 2020
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: ALBANY MOLECULAR RESEARCH, INC.
Reel/Frame 054382/0326 →
Security Interest Mar 7, 2025
From: CURIA GLOBAL, INC.; CURIA IP HOLDINGS, LLC; CURIA BIO, INC.
To: APOLLO ADMINISTRATIVE AGENCY LLC
Reel/Frame 070442/0908 →
Change of Name May 20, 2025
From: ALBANY MOLECULAR RESEARCH, INC.
To: CURIA GLOBAL, INC.
Reel/Frame 071298/0097 →